As such, circulatory CXCL10 was even proposed to be a predictive marker for diagnosis of early RA, monitoring disease activity in established RA and predicting the response to anti-TNF-α treatment [84–87]. This evidence concerns the gene CXCL10 and rheumatoid arthritis.